Alecinix 150 MG (Alectinib)

Basic Product Information of Alecinix (Alectinib) 150mg

How Alecinix (Alectinib) Works

Alecinix contains Alectinib, a highly selective inhibitor of ALK (anaplastic lymphoma kinase). In a subset of NSCLC, a chromosomal rearrangement fuses the ALK gene with another gene (most commonly EML4), producing an abnormal EML4-ALK fusion protein that continuously signals cancer cells to grow and divide.

Alectinib works by binding to and blocking the ALK enzyme, interrupting this abnormal signalling and slowing or stopping tumour growth. As a second-generation ALK inhibitor, Alectinib is designed to achieve good penetration into the central nervous system, making it particularly effective at controlling and preventing brain metastases, a common and challenging complication of ALK-positive lung cancer.

Alecinix is taken as a twice-daily oral capsule with food, which is required for adequate absorption of the medication.

Indications for Alecinix (Alectinib)

Alecinix (Alectinib) is indicated for the following conditions, in patients with ALK-positive disease confirmed by an approved test:

Benefits of Alecinix (Alectinib) 150mg

How to Take Alecinix (Alectinib)

Monitoring and Dosage Adjustments

Regular monitoring is essential during Alecinix treatment. Your healthcare provider will monitor liver function tests every 2 weeks for the first 3 months, then periodically thereafter, given the risk of hepatotoxicity. Monitoring also includes heart rate and blood pressure for bradycardia, renal function, creatine phosphokinase (CPK) for muscle-related side effects, and complete blood counts for signs of haemolytic anaemia. Watchfulness for respiratory symptoms that could indicate interstitial lung disease is also important. Report any new muscle pain or weakness, unusual fatigue, dizziness, shortness of breath, or yellowing of the skin or eyes to your doctor promptly.

Drug Interactions and Important Information

Alectinib and its major active metabolite are metabolised primarily through CYP3A4. Avoid strong CYP3A4 inducers such as rifampin, carbamazepine, phenytoin, and St. John’s Wort, as these can significantly reduce Alectinib levels and efficacy. Caution is advised with strong CYP3A4 inhibitors, and grapefruit or grapefruit juice should generally be avoided.

Alecinix can cause photosensitivity; patients should use sun protection and avoid prolonged sun exposure during treatment. Always inform your physician of all medications, supplements, and herbal products you are currently taking before starting Alecinix.

Side Effects and Precautions

Who Should Use Alecinix (Alectinib)?

Alecinix is suitable for adult patients with ALK-positive metastatic NSCLC, confirmed by an approved diagnostic test, as first-line or subsequent treatment, and for adult patients receiving adjuvant treatment after surgical resection of ALK-positive NSCLC meeting the approved tumour size or nodal criteria. It is prescribed by oncologists and specialist physicians experienced in managing biomarker-driven lung cancer. Confirmed ALK testing, baseline liver function, heart rate assessment, and CPK levels are recommended before starting treatment.

Manufacturer

Alecinix (Alectinib) is manufactured in Bangladesh under strict WHO-GMP, cGMP, and ISO-certified standards, offering an affordable and bioequivalent alternative to Alecensa by Genentech/Roche at a fraction of the cost. [Please confirm the exact manufacturer name so it can be added here and in the specs table above.]

Global Supplier: Mediaid Pharmacy with Worldwide Shipping

Mediaid Pharmacy is a trusted global supplier of specialty oncology medications. We ensure Alecinix (Alectinib) is accessible to patients and healthcare providers worldwide through reliable worldwide shipping. Whether you are located in South Asia, the Middle East, Africa, Europe, or beyond, Mediaid Pharmacy provides fast and reliable delivery with full order support. Contact us directly via WhatsApp, phone, or WeChat for pricing, availability, and delivery enquiries.

Why Choose Alecinix (Alectinib) from Mediaid Pharmacy?

Alecinix represents a preferred targeted therapy option for patients with ALK-positive lung cancer, including those at risk of brain metastases. As the generic equivalent of Alecensa by Genentech/Roche, it delivers the same active ingredient, Alectinib, with the same proven ALK inhibition mechanism at a dramatically more affordable price. Manufactured under WHO-GMP and cGMP standards and distributed globally by Mediaid Pharmacy, Alecinix gives patients worldwide access to high-quality targeted lung cancer therapy without the financial burden of brand-name alternatives. For patients and physicians seeking a proven, affordable, and accessible Alectinib option with worldwide delivery, Alecinix from Mediaid Pharmacy is the trusted choice.

Frequently Asked Questions About Alecinix (Alectinib)